Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

作者：D. Jocham, Axel Richter, Lothar Hoffmann, Klaus Iwig, Dirk Fahlenkamp, G Zakrzewski, Eberhard Schmitt, Thomas Dannenberg, Walter Lehmacher, Jörn von Wietersheim, Christian Doehn · 发表于：The Lancet · 年份：2004 · DOI：10.1016/s0140-6736(04)15590-6 · 被引用次数：436 · 研究领域：Renal cell carcinoma treatment、Immunotherapy and Immune Responses、Cancer Research and Treatments